A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model

作者:Rajput Vishal K; MacKinnon Alison; Mandal Santanu; Collins Patrick; Blanchard Helen; Leffler Hakon; Sethi Tariq; Schambye Hans; Mukhopadhyay Balaram; Nilsson Ulf J*
来源:Journal of Medicinal Chemistry, 2016, 59(17): 8141-8147.
DOI:10.1021/acs.jmedchem.6b00957

摘要

Synthesis of doubly 3-O-coumarylmethyl-substituted, thiodigalactosides from bis-3-O-propargyl-thiodigalactoside resulted in, highly selective and high affinity galectin-3 inhibitors. Mutant studies structural analysis and molecular modeling revealed that the coumaryl substituents stack onto arginine side chains. One inhibitor displayed:: efficacy in a murine model of bleomycin-induced lung fibrosis similar to that of a known nonselective galectin-1/galectin-3 inhibitor, which Strongly suggests that blocking galectin-3 glycan recognition is an important antifibrotic drug target.

  • 出版日期2016-9-8